Reverse causality, in which obesity-induced disease leads to both weight loss and higher mortality, may bias observed associations between body mass index (BMI) and mortality, but the magnitude of that bias is unknown. The authors examined the impact of reverse causality and the exclusion of various diseases on the observed age-specific mortality ratios for BMI by using a state space model and sensitivity analyses. They found that reverse causality may decrease the ratios and induce a J-shaped curve on a graph. The authors further found that the net effect of excluding various diseases becomes a balance of competing forces, some tending to increase observed mortality ratios, where as others, such as selection based on common effects, may decrease them. Instead of studying just the change in observed mortality ratios, which can be misleading, investigators need to consider causal relationships and evaluate the conceptual and theoretical impact of any analytic maneuver. Analyses should be balanced with sensitivity approaches as well as with alternative analytic approaches such as the use of structural models, G-estimation, simulations and ancillary data from animal studies.
Introduction
Reverse causality, a form of bias, must be considered when interpreting studies of obesity and mortality. The basic issue is that obesity-related diseases that result in death can lead to intermediate weight loss and thus obscure the obesitymortality relationship (Figure 1 ). Failure to recognize reverse causality may lead to underestimating the effects of obesity on mortality. 1, 2 The concern with reverse causality is not a new one, but it has been underappreciated. Robins 3 talked about problems with effect definitions. Unmeasured risk factors were the focus of articles in the 1980s and 1990s, 4, 5 and reverse causality was considered specifically within the context of cross-sectional studies 6 and the relation of mortality to height and body mass index (BMI). 7 This article examines the impact of reverse causality and the exclusion of obesityrelated diseases that cause weight loss on the observed age-specific mortality ratios for BMI, using a state space model and sensitivity analyses.
The structural model
The structural model used for this study, depicted schematically in Figure 2 , is characterized by a set of functions, each of which determines the number of people in a particular state in discrete time, depending on the distribution of people in various states at the preceding time. Four BMI states (low, normal, overweight and obese; Figure 2 ) and three health states (disease-free (DÀ), diseased (D þ ) and deceased) are present at each time. Subject to remaining within the available categories, people in each state may increase or decrease a BMI category, and disease-free people can develop disease. Although people in the non-diseased (DÀ) groups could increase or decrease their BMI category, the arrows point only upward to indicate a greater propensity of healthy people transitioning upward rather than downward. Conversely, transition rates for diseased (D þ ) people were set so that they predominantly maintained or decreased their BMI category, reflecting the potential for disease to cause weight loss, the phenomenon hypothesized to underlie reverse causality. Weight gain and loss were adjusted so that the age-specific prevalences of obesity and overweight were similar to those of the US adult population. Further, the incidence of disease was higher in heavier BMI categories, following a logistic model in which the values assigned to each BMI category and age were treated as continuous. A logistic model was also used for mortality, again treating age as continuous and specified so that people in any state could die, with higher transition rates for those with disease. To evaluate the model over time, age-specific mortality rates were set to approximate those in the United States, and we simulated the aging of a cohort from age 25 to 75 years. The proportion of people who transitioned from one state to another was deterministic, according to the specified parameters, which were adjusted so that the age-specific prevalence of overweight (category 3) and obesity (highest category) approximated those in the United States. Patterns are summarized through age-specific mortality and mortality ratios comparing mortality among those in one BMI category with that among those in the referent (second) category.
Simulations and results
In the first scenario considered, we assumed that disease induced almost no weight loss (for example, 0.4% per year more decreased a BMI category among the diseased than among the non-diseased). In this situation (Figure 3a ), the mortality ratios at the age of 60 years increase with increasing BMI and a J-shaped curve is not apparent. Here, the second category is the referent category. A similar pattern of mortality ratios was seen at the age of 75 years (data not shown). The three curves for the age-specific mortality ratios in Figure 3a represent three different populations: in the leftmost curve, the lowest BMI category is set to be about 17. For the middle curve, the lowest BMI category is set to be about 21. For the rightmost curve, the lowest BMI category is set to 25.
In the next simulation, we assumed that disease causes an extra 4% of diseased people to decrease a BMI category annually compared with non-diseased people. Now, mortality follows a J-shaped curve with increasing BMI (Figure 3b ).
When we used absolute rates rather than rate ratios, patterns were similar. For example, the age-specific mortality rates at the age of 60 years when disease causes no weight loss in 4% annually ( Figure 4a ) were similar, as one would expect, to those seen using the corresponding mortality ratios (Figure 3b ).
To analyze the effects of excluding people with disease at the start of follow-up, as might be done in a cohort study to reduce bias associated with reverse causality, we excluded all those who had disease at middle age (age 55 years). Agespecific rates were then lower in every weight category compared with analyses without excluding diseased people, but absolute rates decreased the most for underweight people (Figure 4b ). The resulting patterns depend on the parameters chosen for the model and other factors, such as the characteristics of the excluded diseases. However, the exclusion of diseased people clearly in this scenario ( Figure 4b ) and others not shown clearly affects the absolute rates and tended to reduce or eliminate the J-shaped curve. Overall, these results are consistent with reverse causality and suggest that it could induce a J-shaped curve, as has often been seen. Further, excluding prevalent disease ( Figure 4b ) makes results more similar to those obtained when no impact of disease on weight loss is assumed, as was seen in Figure 3a .
An overall increase in the population BMI was reflected in the simulations by assigning a higher number to each BMI category, which induced changes in the modeled categoryspecific incidence and mortality rates. For the heavier populations, shown in the figures by the two age-specific curves on the right-hand side, the increasing population BMIs caused an apparent flattening of the dose response and a shift in the bottom of the J-shaped curve to the right.
A natural question is, 'Since exclusion of people with certain diseases tends to reduce or eliminate the J-shaped curve, why not simply recommend that approach for analysis of cohort studies?' The answer has several parts. First, this approach would involve selection based on some of the effects of obesity (for example, disease), but these effects are intermediate factors in some pathways from Adjusting for reverse causality WD Flanders and LB Augestad obesity to death. Second, some diseases are common effects of both obesity and other risk factors. Selecting only those who do not have the disease could tend to induce an artifactual association between obesity and these other risk factors ( Figure 5 ). 8 Such an association would tend to result in overestimating the effects of obesity in the selected populationFthe opposite of the impact of reverse causality.
Potentially supporting this possibility, some observational data support a negative association between obesity and mortality with certain diseases. As an example, obesity is a strong risk factor for end-stage renal disease (ESRD). But among those with ESRD, obesity becomes associated with lower mortality. The same reversal of association exists with some other risk factors for ESRD. For instance, African Americans have a higher risk of ESRD, but African Americans with ESRD tend to live longer. A similar relationship exists between obesity and congestive heart failure. Higher BMI is associated with higher risk of developing congestive heart failure but better prognosis after developing it.
There may be a real as well as an artifactual component to such associations. Thus, the net effect of excluding various diseases becomes a balance of competing forces, some tending to increase the observed rate ratios and some tending to decrease them. The balance is difficult to determine because it depends, in part, on unmeasured and perhaps even unknown factors. As a result, the net effect becomes very difficult to determine. 
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Sensitivity analyses and other approaches to reverse causality
Future work could include further assessment of the sensitivity of the results presented here to model assumptions such as the categories used and transition probabilities. In the analyses of observational studies, one could assess the sensitivity of results to controlling for or excluding people with prevalent diseases. Furthermore, one could apply the G-computation algorithm, structural nested failure time models or other approaches based on causal considerations. Because body mass is known to be associated with and is probably causal for certain diseases, and those diseases have an impact on mortality, such factors could be combined at least approximately in a simple conditional probability equation rough check in combination with sensitivity analyses, structural models, simulations, and laboratory and animal data. The synthesis of information from many different sources would allow a more complete understanding of the impact of obesity on mortality and other outcomes.
Conclusions: time-varying confounding
Our simulations show that either the elimination of an effect of obesity on reducing BMI or the exclusion of diseased people can reduce or eliminate the J-shaped pattern that is often seen in studies of mortality and BMI and that has been attributed to reverse causality. Merely documenting reduction or elimination of this pattern, however, does not prove that analyses in which one excludes diseased people are more valid. The problem reflects the complex causal pathways in which adiposity is both a cause of certain illnesses as well as a consequence, and both affect mortality. Analyses in this situation are better conducted using G-estimation, a marginal structural model or other somewhat complex methods. 3, 9 Investigators must consider causal relationships and evaluate the conceptual and theoretical impact of any analytic maneuvers, rather than being content to see if a particular maneuver changes the estimate. Do theory and causal considerations indicate whether an approach is improving validity or worsening it? Are biases from different factors canceling each other out? One can balance analyses with a multipronged approach that includes sensitivity analyses, alternative analytic methods such as the use of structural equations, simulations such as those pointed out here, and ancillary data from laboratory and animal studies. In all our estimates, we need to recognize that there is still a great deal of uncertainty. All of these considerations, including the difficulty of obtaining valid estimates, provide additional impetus to think about effective interventions and the use of randomized controlled trials to study their effects.
